LIG Biowise raises £1.8m for rapid diagnostic kit
Manchester, UK-based LIG Biowise has raised £1.8 million in Series A fundraising, to further develop its ultra-rapid diagnostic device.
Read More
Tag: Biowise
- Elevara begins phase 2b trial of ELV001 in rheumatoid arthritis
- Lebrikizumab shows strong results for children with atopic dermatitis
- MHRA approves new treatment for severe alopecia areata
- Aplagon doses first patient in phase 2a trial of APAC
- NHS to offer fezolinetant for menopause‑related hot flushes and night‑sweats
